The mission of CasInvent Pharma is to bring new therapeutic options for the treatment of selected leukemias to market. We are developing highly selective small molecule inhibitors of casein kinase I (CK1), and our main development program is focused on the identification of new drugs for the treatment of acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL).
CasInvent Pharma was established in 2020 as a spin-off company of Masaryk University in cooperation with the investment partner i&i Prague.
Company Details
- Employees
- 11
- Founded
- 2020
- Address
- Kamenice 34, Office #4.12,czech Republic
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.casinvent.com/
- Keywords
- oncomed manufacturing a.s..
- HQ
- Brno, South Moravia
Casinvent Pharma Questions
Casinvent Pharma's website is https://www.casinvent.com/
Casinvent Pharma's LinkedIn profile is https://cz.linkedin.com/company/casinvent-pharma
Casinvent Pharma has
11 employees.
View email and phone details for 11
employees at Casinvent Pharma.
Casinvent Pharma's industry is
Pharmaceutical Manufacturing
Casinvent Pharma's top competitors are
I&i Prague,
Prague.bio,
Maia Labs,
Jic - Business With A Purpose,
Carebot,
Cf Plus Chemicals S.r.o.,
Forlady Pharma S.r.o.,
Mb Pharma,
Garage Angels,
Oncomed Manufacturing A.s..
Casinvent Pharma's categories are Pharmaceutical Manufacturing
Casinvent Pharma's founding year is 2020
